sAnimal rabies is endemic in Israel, with 50-80 laboratory-confirmed cases
being diagnosed annually. Despite the high incidence among animals, human r
abies has not occurred in Israel for almost four decades. This is likely du
e to the highly effective prevention policy implemented by the Ministry of
Health, based on pre-exposure vaccination of populations at risk, post-expo
sure treatment, and updated rules.
Notwithstanding the previous success, a human case occurred in 1996 when a
soldier was bitten, while asleep, by an unidentified small animal, which ac
cording to his description was a rat or a mouse. Since injuries by these ro
dents do not require antirabies treatment, no antirabies post-exposure prop
hylaxis was administered. Five weeks later the soldier complained of fever
and nausea with interchanging periods of rage and calm, confusion, and wate
r aversion. His condition deteriorated gradually, leading to deep coma and
death. Immunofluorescence examination of a skin biopsy was positive for rab
ies, and PCR of saliva revealed Lyssavirus genotype 1.
We review the changes in the epizootiology of rabies in Israel, the trends
of human exposure to animals, and the pre- and post-exposure prophylaxis gu
idelines, and discuss possible measures that could have been undertaken to
prevent the eventuality of this case. This case of rabies, the first after
a long period without human disease, accentuates the importance of strict a
dherence to prevention guidelines. Considerations of geography, epidemiolog
y, and the circumstances of exposure are crucial in the treatment decision-
making process.